Índice

• • ·WHO launches its Global Action Plan for brain health

    Página :671

     
• • ·Further support for rituximab in relapsing multiple sclerosis

    Página :672-673

    Robert T Naismith, Anne H Cross

    
• • ·Improving prognostication after severe brain injury

    Página :673-674

    Adrian M Owen OBE

     
• • ·Cerebral amyloid angiopathy criteria: the next generation

    Página :674-676

    Jonathan Graff-Radford, Alejandro A Rabinstein

    
• • ·The importance of genomics in advancing the diagnosis and treatment of dementia

    Página :676-677

    Boris Decourt, Marwan N Sabbagh

     
• • ·Major advances in sleep neurology: 2002–22

    Página :678-680

    Thomas E Scammell, Clifford B Saper

     
• • ·Antibiotic neuromuscular junction myasthenic mimetics

    Página :681

    Chika Edward Uzoigwe, Frederick Campbell-Jones

    
• • ·Antibiotic neuromuscular junction myasthenic mimetics – Authors’ reply

    Página :681

    Maartje G Huijbers, Anna Punga, Jan J Verschuuren

     
• • ·Exercise training and neuroprotection in multiple sclerosis

    Página :681-682

    Lars G Hvid, Martin Langeskov-Christensen, Egon Stenager, Ulrik Dalgas

    
• • ·Interferon receptor dysfunction in a child with malignant atrophic papulosis and CNS involvement

    Página :682-686

    Lena-Luise Becker, Frédéric Ebstein, Denise Horn, Christos C Zouboulis, Elke Krüger, Angela M Kaindl, IFNAR1 Research Group, Anna Tietze, Angelika Eger, Tilmann Kallinich, Saskia Biskup, Simone Schmid, Werner Stenzel, Hanna Münzfeld, Ulrike Blume-Peytavi

      
• • ·Time to revise primary prevention guidelines for stroke and cardiovascular disease

    Página :686-687

    Michael Brainin, World Stroke Organization, Wolfgang Grisold, World Federation of Neurology, Graeme J Hankey, Bo Norrving, Valery L Feigin

    
• • ·Linda de Vries: intervening early to improve young lives

    Página :688

    Udani Samarasekera

     
• • ·West Syndrome and the new classification of epilepsy

    Página :689

    Elia M Pestana Knight, Elaine Wyllie

    
• • ·Andreas Charidimou

    Página :689

     
• • ·A blueprint for the worldwide research response to dementia

    Página :690-691

    Rodrigo Cataldi, Neerja Chowdhary, Katrin Seeher, Vasee Moorthy, Tarun Dua

     
• • ·The drive and determination of John Hughlings Jackson

    Página :692

    Eelco Wijdicks

     
• • ·Safety and efficacy of rituximab versus dimethyl fumarate in patients with relapsing-remitting multiple sclerosis or clinically isolated syndrome in Sweden: a rater-blinded, phase 3, randomised controlled trial

    Página :693-703

    Anders Svenningsson, Thomas Frisell, Joachim Burman, Jonatan Salzer, Katharina Fink, Susanna Hallberg, Joakim Hambraeus, Markus Axelsson, Faiez Al Nimer, Peter Sundström, Martin Gunnarsson, Rune Johansson, Johan Mellergård, Igal Rosenstein, Ahmad Ayad, Irina Sjöblom, Anette Risedal, Pierre de Flon, Eric Gilland, Jonas Lindeberg, Fadi Shawket, Fredrik Piehl, Jan Lycke

    Resumen Resumen Esquema Esquema   
• • ·Cognitive-motor dissociation and time to functional recovery in patients with acute brain injury in the USA: a prospective observational cohort study

    Página :704-713

    Jennifer Egbebike, Qi Shen, Kevin Doyle, Caroline A Der-Nigoghossian, Lucy Panicker, Ian Jerome Gonzales, Lauren Grobois, Jerina C Carmona, Athina Vrosgou, Arshneil Kaur, Amelia Boehme, Angela Velazquez, Benjamin Rohaut, David Roh, Sachin Agarwal, Soojin Park, E Sander Connolly, Jan Claassen

    Resumen Resumen Esquema Esquema   
• • ·The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI–neuropathology diagnostic accuracy study

    Página :714-725

    Andreas Charidimou, Gregoire Boulouis, Matthew P Frosch, Jean-Claude Baron, Marco Pasi, Jean Francois Albucher, Gargi Banerjee, Carmen Barbato, Fabrice Bonneville, Sebastian Brandner, Lionel Calviere, François Caparros, Barbara Casolla, Charlotte Cordonnier, Marie-Bernadette Delisle, Vincent Deramecourt, Martin Dichgans, Elif Gokcal, Jochen Herms, Mar Hernandez-Guillamon, Hans Rolf Jäger, Zane Jaunmuktane, Jennifer Linn, Sergi Martinez-Ramirez, Elena Martínez-Sáez, Christian Mawrin, Joan Montaner, Solene Moulin, Jean-Marc Olivot, Fabrizio Piazza, Laurent Puy, Nicolas Raposo, Mark A Rodrigues, Sigrun Roeber, Jose Rafael Romero, Neshika Samarasekera, Julie A Schneider, Stefanie Schreiber, Frank Schreiber, Corentin Schwall, Colin Smith, Levente Szalardy, Pascale Varlet, Alain Viguier, Joanna M Wardlaw, Andrew Warren, Frank A Wollenweber, Marialuisa Zedde, Mark A van Buchem, M Edip Gurol, Anand Viswanathan, Rustam Al-Shahi Salman, Eric E Smith, David J Werring, Steven M Greenberg

    Resumen Resumen Esquema Esquema   
• • ·Tau biomarkers in Alzheimer’s disease: towards implementation in clinical practice and trials

    Página :726-734

    Rik Ossenkoppele, Rik van der Kant, Oskar Hansson

    Resumen Resumen Esquema Esquema  
• • ·Diagnosis and treatment of orthostatic hypotension

    Página :735-746

    Wouter Wieling, Horacio Kaufmann, Victoria E Claydon, Veera K van Wijnen, Mark P M Harms, Stephen P Juraschek, Roland D Thijs

    Resumen Resumen Esquema Esquema  
• • ·Moyamoya disease: diagnosis and interventions

    Página :747-758

    Masafumi Ihara, Yumi Yamamoto, Yorito Hattori, Wanyang Liu, Hatasu Kobayashi, Hiroyuki Ishiyama, Takeshi Yoshimoto, Satoru Miyawaki, Tim Clausen, Oh Young Bang, Gary K Steinberg, Elisabeth Tournier-Lasserve, Akio Koizumi

    Resumen Resumen Esquema Esquema